NATAMYCIN
别名和识别信息
NATAMYCININCINATAMYCIN동의어
- cas
- 7681-93-8
- ec
- 231-683-5 (I)
- dtxsid
- DTXSID6021163
- dtxcid
- DTXCID301163
- IUPAC
- (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-Amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20- pentaene-25-carboxylic acid
- 분자식
- C33H47NO13
- 분자량
- 665.733 g/mol
化妆品中的作用
PRESERVATIVEANTIMICROBIAL
相关文献
- Ethosomes - based natamycin delivery system: a potential approach for treating fungal infection · 2025
- Comparative Evaluation of Topical Monotherapy (Natamycin or Natasol) and Combination Therapy (Natamycin and Voriconazole) in Mild-Moderate Fungal Keratitis. · 2024
- Physiochemical Characterization of Lipidic Nanoformulations Encapsulating the Antifungal Drug Natamycin · 2024
- Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics · 2023
- Novel Water Soluble Sterile Natamycin Formulation (Natasol) for Fungal Keratitis. · 2021